• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠病毒肺炎患者入院时的预测性风险因素及住院期间的“转折点”可作为危重症的连续警示信号。

Predictive Risk Factors at Admission and a "Burning Point" During Hospitalization Serve as Sequential Alerts for Critical Illness in Patients With COVID-19.

作者信息

Yin Zhengrong, Zhou Mei, Xu Juanjuan, Wang Kai, Hao Xingjie, Tan Xueyun, Li Hui, Wang Fen, Dai Chengguqiu, Ma Guanzhou, Wang Zhihui, Duan Limin, Jin Yang

机构信息

Key Laboratory of Pulmonary Diseases of National Health Commission, Department of Respiratory and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

State Key Laboratory of Environmental Health (Incubating), Department of Epidemiology and Biostatistics, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

出版信息

Front Med (Lausanne). 2022 Jul 4;9:816314. doi: 10.3389/fmed.2022.816314. eCollection 2022.

DOI:10.3389/fmed.2022.816314
PMID:35860737
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9291637/
Abstract

BACKGROUND

We intended to establish a novel critical illness prediction system combining baseline risk factors with dynamic laboratory tests for patients with coronavirus disease 2019 (COVID-19).

METHODS

We evaluated patients with COVID-19 admitted to Wuhan West Union Hospital between 12 January and 25 February 2020. The data of patients were collected, and the illness severity was assessed.

RESULTS

Among 1,150 enrolled patients, 296 (25.7%) patients developed into critical illness. A baseline nomogram model consists of seven variables including age [odds ratio (OR), 1.028; 95% confidence interval (CI), 1.004-1.052], sequential organ failure assessment (SOFA) score (OR, 4.367; 95% CI, 3.230-5.903), neutrophil-to-lymphocyte ratio (NLR; OR, 1.094; 95% CI, 1.024-1.168), D-dimer (OR, 1.476; 95% CI, 1.107-1.968), lactate dehydrogenase (LDH; OR, 1.004; 95% CI, 1.001-1.006), international normalised ratio (INR; OR, 1.027; 95% CI, 0.999-1.055), and pneumonia area interpreted from computed tomography (CT) images (medium vs. small [OR, 4.358; 95% CI, 2.188-8.678], and large vs. small [OR, 9.567; 95% CI, 3.982-22.986]) were established to predict the risk for critical illness at admission. The differentiating power of this nomogram scoring system was perfect with an area under the curve (AUC) of 0.960 (95% CI, 0.941-0.972) in the training set and an AUC of 0.958 (95% CI, 0.936-0.980) in the testing set. In addition, a linear mixed model (LMM) based on dynamic change of seven variables consisting of SOFA score (value, 2; increase per day [I/d], +0.49), NLR (value, 10.61; I/d, +2.07), C-reactive protein (CRP; value, 46.9 mg/L; I/d, +4.95), glucose (value, 7.83 mmol/L; I/d, +0.2), D-dimer (value, 6.08 μg/L; I/d, +0.28), LDH (value, 461 U/L; I/d, +13.95), and blood urea nitrogen (BUN value, 6.51 mmol/L; I/d, +0.55) were established to assist in predicting occurrence time of critical illness onset during hospitalization.

CONCLUSION

The two-checkpoint system could assist in accurately and dynamically predicting critical illness and timely adjusting the treatment regimen for patients with COVID-19.

摘要

背景

我们旨在建立一种新型的危重症预测系统,该系统将基线风险因素与动态实验室检查相结合,用于预测2019冠状病毒病(COVID-19)患者的病情。

方法

我们对2020年1月12日至2月25日期间收治于武汉协和医院西区的COVID-19患者进行了评估。收集患者的数据,并评估疾病严重程度。

结果

在1150例登记患者中,296例(25.7%)发展为危重症。建立了一个基线列线图模型,该模型由七个变量组成,包括年龄[比值比(OR),1.028;95%置信区间(CI),1.004 - 1.052]、序贯器官衰竭评估(SOFA)评分(OR,4.367;95% CI,3.230 - 5.903)、中性粒细胞与淋巴细胞比值(NLR;OR,1.094;95% CI,1.024 - 1.168)、D - 二聚体(OR,1.476;95% CI,1.107 - 1.968)、乳酸脱氢酶(LDH;OR,1.004;95% CI,1.001 - 1.006)、国际标准化比值(INR;OR,1.027;95% CI,0.999 - 1.055)以及根据计算机断层扫描(CT)图像解读的肺炎面积(中等面积与小面积相比[OR,4.358;95% CI,2.188 - 8.678],大面积与小面积相比[OR,9.567;95% CI,3.982 - 22.986]),用于预测入院时发展为危重症的风险。该列线图评分系统的区分能力良好,在训练集中曲线下面积(AUC)为0.960(95% CI,0.941 - 0.972),在测试集中AUC为0.958(95% CI,0.936 - 0.980)。此外,基于由SOFA评分(值为2;每日增加量[I/d],+0.49)、NLR(值为10.61;I/d,+2.07)、C反应蛋白(CRP;值为46.9 mg/L;I/d,+4.95)、血糖(值为7.83 mmol/L;I/d,+0.2)、D - 二聚体(值为6.08 μg/L;I/d,+0.28)、LDH(值为461 U/L;I/d,+13.95)和血尿素氮(BUN值为6.51 mmol/L;I/d,+0.55)组成的七个变量的动态变化建立了线性混合模型(LMM),以协助预测住院期间危重症发病的发生时间。

结论

双检查点系统可协助准确、动态地预测COVID-19患者的危重症情况,并及时调整治疗方案。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a39a/9291637/1187ef26b383/fmed-09-816314-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a39a/9291637/5c61320674a4/fmed-09-816314-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a39a/9291637/2411647abdc1/fmed-09-816314-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a39a/9291637/1187ef26b383/fmed-09-816314-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a39a/9291637/5c61320674a4/fmed-09-816314-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a39a/9291637/2411647abdc1/fmed-09-816314-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a39a/9291637/1187ef26b383/fmed-09-816314-g003.jpg

相似文献

1
Predictive Risk Factors at Admission and a "Burning Point" During Hospitalization Serve as Sequential Alerts for Critical Illness in Patients With COVID-19.新冠病毒肺炎患者入院时的预测性风险因素及住院期间的“转折点”可作为危重症的连续警示信号。
Front Med (Lausanne). 2022 Jul 4;9:816314. doi: 10.3389/fmed.2022.816314. eCollection 2022.
2
[Relationship between D-dimer concentration and inflammatory factors or organ function in patients with coronavirus disease 2019].2019冠状病毒病患者D-二聚体浓度与炎症因子或器官功能的关系
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 May;32(5):559-563. doi: 10.3760/cma.j.cn121430-20200414-00518.
3
[Combined predictive value of the risk factors influencing the short-term prognosis of sepsis].[影响脓毒症短期预后的危险因素的联合预测价值]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Mar;32(3):307-312. doi: 10.3760/cma.j.cn121430-20200306-00218.
4
Dynamic changes of D-dimer and neutrophil-lymphocyte count ratio as prognostic biomarkers in COVID-19.新冠肺炎患者 D-二聚体和中性粒细胞-淋巴细胞比值的动态变化作为预后生物标志物。
Respir Res. 2020 Jul 3;21(1):169. doi: 10.1186/s12931-020-01428-7.
5
Prognostic value of neutrophil-to-lymphocyte ratio, lactate dehydrogenase, D-dimer, and computed tomography score in patients with coronavirus disease 2019.中性粒细胞与淋巴细胞比值、乳酸脱氢酶、D-二聚体和计算机断层扫描评分对新型冠状病毒肺炎患者的预后价值。
Aging (Albany NY). 2021 Sep 8;13(17):20896-20905. doi: 10.18632/aging.203501.
6
Risk factors for the critical illness in SARS-CoV-2 infection: a multicenter retrospective cohort study.严重急性呼吸综合征冠状病毒 2 感染患者发生危重症的危险因素:一项多中心回顾性队列研究。
Respir Res. 2020 Oct 21;21(1):277. doi: 10.1186/s12931-020-01492-z.
7
[Value of neutrophil-to-lymphocyte ratio in the classification diagnosis of coronavirus disease 2019].[中性粒细胞与淋巴细胞比值在新型冠状病毒肺炎分型诊断中的价值]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 May;32(5):554-558. doi: 10.3760/cma.j.cn121430-20200413-00506.
8
[Combined prognostic value of serum lactic acid, procalcitonin and severity score for short-term prognosis of septic shock patients].[血清乳酸、降钙素原及严重程度评分对脓毒症休克患者短期预后的联合预测价值]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021 Mar;33(3):281-285. doi: 10.3760/cma.j.cn121430-20201113-00715.
9
Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19.开发和验证一种临床风险评分,以预测 COVID-19 住院患者发生危重症的情况。
JAMA Intern Med. 2020 Aug 1;180(8):1081-1089. doi: 10.1001/jamainternmed.2020.2033.
10
[Predictive value of neutrophil to lymphocyte ratio in the progression of sepsis to chronic critical illness in elderly patients].[中性粒细胞与淋巴细胞比值对老年患者脓毒症进展为慢性危重病的预测价值]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021 Nov;33(11):1291-1295. doi: 10.3760/cma.j.cn121430-20210628-00952.

本文引用的文献

1
Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron.奥密克戎变异株 B.1.1.529 对 SARS-CoV-2 的复制和致病性减弱。
Nature. 2022 Mar;603(7902):693-699. doi: 10.1038/s41586-022-04442-5. Epub 2022 Jan 21.
2
Epidemiological Characteristics of 69,382 COVID-19 Patients in Oman.阿曼 69382 例 COVID-19 患者的流行病学特征。
J Epidemiol Glob Health. 2021 Dec;11(4):326-337. doi: 10.1007/s44197-021-00001-9. Epub 2021 Aug 4.
3
Evaluation of COVID-19 Mortality and Adverse Outcomes in US Patients With or Without Cancer.
评估有或无癌症的美国 COVID-19 患者的死亡率和不良结局。
JAMA Oncol. 2022 Jan 1;8(1):69-78. doi: 10.1001/jamaoncol.2021.5148.
4
Clinical Predictors of Mortality and Critical Illness in Patients with COVID-19 Pneumonia.新冠肺炎患者死亡和危重症的临床预测因素
Metabolites. 2021 Oct 2;11(10):679. doi: 10.3390/metabo11100679.
5
Longitudinal ventilatory ratio monitoring for COVID-19: its potential in predicting severity and assessing treatment response.COVID-19的纵向通气比率监测:其在预测严重程度和评估治疗反应方面的潜力。
Crit Care. 2021 Oct 20;25(1):366. doi: 10.1186/s13054-021-03768-2.
6
Development and validation of nomogram to predict severe illness requiring intensive care follow up in hospitalized COVID-19 cases.建立并验证列线图预测 COVID-19 住院患者需要重症监护随访的严重疾病风险。
BMC Infect Dis. 2021 Sep 25;21(1):1004. doi: 10.1186/s12879-021-06656-w.
7
The biological and clinical significance of emerging SARS-CoV-2 variants.新兴 SARS-CoV-2 变体的生物学和临床意义。
Nat Rev Genet. 2021 Dec;22(12):757-773. doi: 10.1038/s41576-021-00408-x. Epub 2021 Sep 17.
8
Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study.ISARIC 4C 成人 COVID-19 恶化模型的开发和验证:一项前瞻性队列研究。
Lancet Respir Med. 2021 Apr;9(4):349-359. doi: 10.1016/S2213-2600(20)30559-2. Epub 2021 Jan 11.
9
Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2.开发一种具有强大预防 SARS-CoV-2 能力的灭活疫苗候选物,BBIBP-CorV。
Cell. 2020 Aug 6;182(3):713-721.e9. doi: 10.1016/j.cell.2020.06.008. Epub 2020 Jun 6.
10
Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection.免疫补体和凝血功能障碍与 SARS-CoV-2 感染的不良结局。
Nat Med. 2020 Oct;26(10):1609-1615. doi: 10.1038/s41591-020-1021-2. Epub 2020 Aug 3.